alfimeprase
alfimeprase is a pharmaceutical drug with 7 clinical trials. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
Clinical Trials (7)
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery
Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7